nodes	percent_of_prediction	percent_of_DWPC	metapath
Mannitol—ABCB1—Tamoxifen—pancreatic cancer	0.131	0.199	CbGbCtD
Mannitol—ABCB1—Gemcitabine—pancreatic cancer	0.113	0.172	CbGbCtD
Mannitol—ABCB1—Erlotinib—pancreatic cancer	0.111	0.169	CbGbCtD
Mannitol—ABCB1—Irinotecan—pancreatic cancer	0.101	0.153	CbGbCtD
Mannitol—ABCB1—Docetaxel—pancreatic cancer	0.0738	0.112	CbGbCtD
Mannitol—ABCB1—Sunitinib—pancreatic cancer	0.0734	0.112	CbGbCtD
Mannitol—ABCB1—Doxorubicin—pancreatic cancer	0.055	0.0835	CbGbCtD
Mannitol—Discomfort—Fluorouracil—pancreatic cancer	0.000479	0.0014	CcSEcCtD
Mannitol—Nervous system disorder—Irinotecan—pancreatic cancer	0.000476	0.00139	CcSEcCtD
Mannitol—Rhinitis—Docetaxel—pancreatic cancer	0.000473	0.00138	CcSEcCtD
Mannitol—Oedema—Gemcitabine—pancreatic cancer	0.000472	0.00138	CcSEcCtD
Mannitol—Cardiac failure—Epirubicin—pancreatic cancer	0.000471	0.00138	CcSEcCtD
Mannitol—Diarrhoea—Tamoxifen—pancreatic cancer	0.00047	0.00138	CcSEcCtD
Mannitol—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000469	0.00137	CcSEcCtD
Mannitol—Infection—Gemcitabine—pancreatic cancer	0.000469	0.00137	CcSEcCtD
Mannitol—Pharyngitis—Docetaxel—pancreatic cancer	0.000468	0.00137	CcSEcCtD
Mannitol—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000466	0.00136	CcSEcCtD
Mannitol—Body temperature increased—Sunitinib—pancreatic cancer	0.000465	0.00136	CcSEcCtD
Mannitol—Diarrhoea—Erlotinib—pancreatic cancer	0.000465	0.00136	CcSEcCtD
Mannitol—Oedema—Fluorouracil—pancreatic cancer	0.000464	0.00136	CcSEcCtD
Mannitol—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000464	0.00136	CcSEcCtD
Mannitol—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000463	0.00136	CcSEcCtD
Mannitol—Urethral disorder—Docetaxel—pancreatic cancer	0.000463	0.00135	CcSEcCtD
Mannitol—Hyponatraemia—Epirubicin—pancreatic cancer	0.000462	0.00135	CcSEcCtD
Mannitol—Infection—Fluorouracil—pancreatic cancer	0.000461	0.00135	CcSEcCtD
Mannitol—Pain in extremity—Epirubicin—pancreatic cancer	0.00046	0.00135	CcSEcCtD
Mannitol—Skin disorder—Gemcitabine—pancreatic cancer	0.000459	0.00134	CcSEcCtD
Mannitol—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000456	0.00133	CcSEcCtD
Mannitol—Dizziness—Tamoxifen—pancreatic cancer	0.000455	0.00133	CcSEcCtD
Mannitol—Tachycardia—Fluorouracil—pancreatic cancer	0.000453	0.00133	CcSEcCtD
Mannitol—Hypotension—Irinotecan—pancreatic cancer	0.000453	0.00133	CcSEcCtD
Mannitol—Dizziness—Erlotinib—pancreatic cancer	0.00045	0.00132	CcSEcCtD
Mannitol—Hypotension—Gemcitabine—pancreatic cancer	0.000441	0.00129	CcSEcCtD
Mannitol—Vomiting—Tamoxifen—pancreatic cancer	0.000437	0.00128	CcSEcCtD
Mannitol—Cardiac failure—Doxorubicin—pancreatic cancer	0.000436	0.00128	CcSEcCtD
Mannitol—Hypotension—Fluorouracil—pancreatic cancer	0.000434	0.00127	CcSEcCtD
Mannitol—Hypersensitivity—Sunitinib—pancreatic cancer	0.000434	0.00127	CcSEcCtD
Mannitol—Rash—Tamoxifen—pancreatic cancer	0.000433	0.00127	CcSEcCtD
Mannitol—Dermatitis—Tamoxifen—pancreatic cancer	0.000433	0.00127	CcSEcCtD
Mannitol—Vomiting—Erlotinib—pancreatic cancer	0.000432	0.00127	CcSEcCtD
Mannitol—Dyspnoea—Irinotecan—pancreatic cancer	0.000432	0.00127	CcSEcCtD
Mannitol—Headache—Tamoxifen—pancreatic cancer	0.000431	0.00126	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00043	0.00126	CcSEcCtD
Mannitol—Rash—Erlotinib—pancreatic cancer	0.000429	0.00125	CcSEcCtD
Mannitol—Dermatitis—Erlotinib—pancreatic cancer	0.000428	0.00125	CcSEcCtD
Mannitol—Dehydration—Epirubicin—pancreatic cancer	0.000428	0.00125	CcSEcCtD
Mannitol—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000427	0.00125	CcSEcCtD
Mannitol—Headache—Erlotinib—pancreatic cancer	0.000426	0.00125	CcSEcCtD
Mannitol—Pain in extremity—Doxorubicin—pancreatic cancer	0.000426	0.00125	CcSEcCtD
Mannitol—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000425	0.00124	CcSEcCtD
Mannitol—Chills—Docetaxel—pancreatic cancer	0.000423	0.00124	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000423	0.00124	CcSEcCtD
Mannitol—Asthenia—Sunitinib—pancreatic cancer	0.000422	0.00124	CcSEcCtD
Mannitol—Decreased appetite—Irinotecan—pancreatic cancer	0.000422	0.00123	CcSEcCtD
Mannitol—Dyspnoea—Gemcitabine—pancreatic cancer	0.000421	0.00123	CcSEcCtD
Mannitol—Abdominal pain upper—Epirubicin—pancreatic cancer	0.00042	0.00123	CcSEcCtD
Mannitol—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000419	0.00123	CcSEcCtD
Mannitol—Fatigue—Irinotecan—pancreatic cancer	0.000418	0.00122	CcSEcCtD
Mannitol—Pruritus—Sunitinib—pancreatic cancer	0.000417	0.00122	CcSEcCtD
Mannitol—Pain—Irinotecan—pancreatic cancer	0.000415	0.00121	CcSEcCtD
Mannitol—Dyspnoea—Fluorouracil—pancreatic cancer	0.000414	0.00121	CcSEcCtD
Mannitol—Mental disorder—Docetaxel—pancreatic cancer	0.000413	0.00121	CcSEcCtD
Mannitol—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000411	0.0012	CcSEcCtD
Mannitol—Malnutrition—Docetaxel—pancreatic cancer	0.000411	0.0012	CcSEcCtD
Mannitol—Decreased appetite—Gemcitabine—pancreatic cancer	0.000411	0.0012	CcSEcCtD
Mannitol—Nausea—Tamoxifen—pancreatic cancer	0.000408	0.00119	CcSEcCtD
Mannitol—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000408	0.00119	CcSEcCtD
Mannitol—Fatigue—Gemcitabine—pancreatic cancer	0.000407	0.00119	CcSEcCtD
Mannitol—Pain—Gemcitabine—pancreatic cancer	0.000404	0.00118	CcSEcCtD
Mannitol—Nausea—Erlotinib—pancreatic cancer	0.000404	0.00118	CcSEcCtD
Mannitol—Decreased appetite—Fluorouracil—pancreatic cancer	0.000404	0.00118	CcSEcCtD
Mannitol—Diarrhoea—Sunitinib—pancreatic cancer	0.000403	0.00118	CcSEcCtD
Mannitol—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000401	0.00117	CcSEcCtD
Mannitol—Feeling abnormal—Irinotecan—pancreatic cancer	0.0004	0.00117	CcSEcCtD
Mannitol—Back pain—Docetaxel—pancreatic cancer	0.000397	0.00116	CcSEcCtD
Mannitol—Pain—Fluorouracil—pancreatic cancer	0.000397	0.00116	CcSEcCtD
Mannitol—Dehydration—Doxorubicin—pancreatic cancer	0.000396	0.00116	CcSEcCtD
Mannitol—Dizziness—Sunitinib—pancreatic cancer	0.000389	0.00114	CcSEcCtD
Mannitol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000389	0.00114	CcSEcCtD
Mannitol—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000389	0.00114	CcSEcCtD
Mannitol—Angina pectoris—Epirubicin—pancreatic cancer	0.000387	0.00113	CcSEcCtD
Mannitol—Body temperature increased—Irinotecan—pancreatic cancer	0.000383	0.00112	CcSEcCtD
Mannitol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000383	0.00112	CcSEcCtD
Mannitol—Bronchitis—Epirubicin—pancreatic cancer	0.000382	0.00112	CcSEcCtD
Mannitol—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000381	0.00111	CcSEcCtD
Mannitol—Vomiting—Sunitinib—pancreatic cancer	0.000374	0.0011	CcSEcCtD
Mannitol—Body temperature increased—Gemcitabine—pancreatic cancer	0.000373	0.00109	CcSEcCtD
Mannitol—Rash—Sunitinib—pancreatic cancer	0.000371	0.00109	CcSEcCtD
Mannitol—Dermatitis—Sunitinib—pancreatic cancer	0.000371	0.00109	CcSEcCtD
Mannitol—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.00037	0.00108	CcSEcCtD
Mannitol—Urticaria—Fluorouracil—pancreatic cancer	0.000369	0.00108	CcSEcCtD
Mannitol—Headache—Sunitinib—pancreatic cancer	0.000369	0.00108	CcSEcCtD
Mannitol—Body temperature increased—Fluorouracil—pancreatic cancer	0.000367	0.00107	CcSEcCtD
Mannitol—Cough—Docetaxel—pancreatic cancer	0.000358	0.00105	CcSEcCtD
Mannitol—Angina pectoris—Doxorubicin—pancreatic cancer	0.000358	0.00105	CcSEcCtD
Mannitol—Hypersensitivity—Irinotecan—pancreatic cancer	0.000357	0.00105	CcSEcCtD
Mannitol—Convulsion—Docetaxel—pancreatic cancer	0.000356	0.00104	CcSEcCtD
Mannitol—Hypertension—Docetaxel—pancreatic cancer	0.000355	0.00104	CcSEcCtD
Mannitol—Infestation NOS—Epirubicin—pancreatic cancer	0.000355	0.00104	CcSEcCtD
Mannitol—Infestation—Epirubicin—pancreatic cancer	0.000355	0.00104	CcSEcCtD
Mannitol—Bronchitis—Doxorubicin—pancreatic cancer	0.000354	0.00104	CcSEcCtD
Mannitol—Arthralgia—Docetaxel—pancreatic cancer	0.00035	0.00102	CcSEcCtD
Mannitol—Chest pain—Docetaxel—pancreatic cancer	0.00035	0.00102	CcSEcCtD
Mannitol—Nausea—Sunitinib—pancreatic cancer	0.00035	0.00102	CcSEcCtD
Mannitol—Renal failure—Epirubicin—pancreatic cancer	0.000349	0.00102	CcSEcCtD
Mannitol—Asthenia—Irinotecan—pancreatic cancer	0.000348	0.00102	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000347	0.00102	CcSEcCtD
Mannitol—Stomatitis—Epirubicin—pancreatic cancer	0.000346	0.00101	CcSEcCtD
Mannitol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000342	0.001	CcSEcCtD
Mannitol—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000342	0.001	CcSEcCtD
Mannitol—Asthenia—Gemcitabine—pancreatic cancer	0.000339	0.000992	CcSEcCtD
Mannitol—Oedema—Docetaxel—pancreatic cancer	0.000335	0.000981	CcSEcCtD
Mannitol—Pruritus—Gemcitabine—pancreatic cancer	0.000334	0.000978	CcSEcCtD
Mannitol—Infection—Docetaxel—pancreatic cancer	0.000333	0.000975	CcSEcCtD
Mannitol—Diarrhoea—Irinotecan—pancreatic cancer	0.000332	0.000971	CcSEcCtD
Mannitol—Nervous system disorder—Docetaxel—pancreatic cancer	0.000329	0.000962	CcSEcCtD
Mannitol—Pruritus—Fluorouracil—pancreatic cancer	0.000329	0.000962	CcSEcCtD
Mannitol—Infestation NOS—Doxorubicin—pancreatic cancer	0.000328	0.00096	CcSEcCtD
Mannitol—Infestation—Doxorubicin—pancreatic cancer	0.000328	0.00096	CcSEcCtD
Mannitol—Tachycardia—Docetaxel—pancreatic cancer	0.000327	0.000958	CcSEcCtD
Mannitol—Skin disorder—Docetaxel—pancreatic cancer	0.000326	0.000953	CcSEcCtD
Mannitol—Diarrhoea—Gemcitabine—pancreatic cancer	0.000323	0.000946	CcSEcCtD
Mannitol—Renal failure—Doxorubicin—pancreatic cancer	0.000322	0.000944	CcSEcCtD
Mannitol—Dizziness—Irinotecan—pancreatic cancer	0.000321	0.000939	CcSEcCtD
Mannitol—Stomatitis—Doxorubicin—pancreatic cancer	0.00032	0.000936	CcSEcCtD
Mannitol—Rhinitis—Epirubicin—pancreatic cancer	0.000319	0.000934	CcSEcCtD
Mannitol—Diarrhoea—Fluorouracil—pancreatic cancer	0.000318	0.00093	CcSEcCtD
Mannitol—Pharyngitis—Epirubicin—pancreatic cancer	0.000316	0.000924	CcSEcCtD
Mannitol—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000314	0.00092	CcSEcCtD
Mannitol—Hypotension—Docetaxel—pancreatic cancer	0.000313	0.000917	CcSEcCtD
Mannitol—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000313	0.000915	CcSEcCtD
Mannitol—Urethral disorder—Epirubicin—pancreatic cancer	0.000312	0.000913	CcSEcCtD
Mannitol—Vomiting—Irinotecan—pancreatic cancer	0.000308	0.000902	CcSEcCtD
Mannitol—Dizziness—Fluorouracil—pancreatic cancer	0.000307	0.000899	CcSEcCtD
Mannitol—Rash—Irinotecan—pancreatic cancer	0.000306	0.000895	CcSEcCtD
Mannitol—Dermatitis—Irinotecan—pancreatic cancer	0.000306	0.000894	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000305	0.000894	CcSEcCtD
Mannitol—Headache—Irinotecan—pancreatic cancer	0.000304	0.000889	CcSEcCtD
Mannitol—Vomiting—Gemcitabine—pancreatic cancer	0.0003	0.000879	CcSEcCtD
Mannitol—Dyspnoea—Docetaxel—pancreatic cancer	0.000299	0.000875	CcSEcCtD
Mannitol—Rash—Gemcitabine—pancreatic cancer	0.000298	0.000872	CcSEcCtD
Mannitol—Dermatitis—Gemcitabine—pancreatic cancer	0.000298	0.000871	CcSEcCtD
Mannitol—Headache—Gemcitabine—pancreatic cancer	0.000296	0.000866	CcSEcCtD
Mannitol—Vomiting—Fluorouracil—pancreatic cancer	0.000295	0.000864	CcSEcCtD
Mannitol—Rhinitis—Doxorubicin—pancreatic cancer	0.000295	0.000864	CcSEcCtD
Mannitol—Rash—Fluorouracil—pancreatic cancer	0.000293	0.000857	CcSEcCtD
Mannitol—Dermatitis—Fluorouracil—pancreatic cancer	0.000293	0.000856	CcSEcCtD
Mannitol—Pharyngitis—Doxorubicin—pancreatic cancer	0.000292	0.000855	CcSEcCtD
Mannitol—Decreased appetite—Docetaxel—pancreatic cancer	0.000291	0.000853	CcSEcCtD
Mannitol—Headache—Fluorouracil—pancreatic cancer	0.000291	0.000852	CcSEcCtD
Mannitol—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000291	0.000851	CcSEcCtD
Mannitol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000289	0.000847	CcSEcCtD
Mannitol—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000289	0.000847	CcSEcCtD
Mannitol—Fatigue—Docetaxel—pancreatic cancer	0.000289	0.000846	CcSEcCtD
Mannitol—Urethral disorder—Doxorubicin—pancreatic cancer	0.000289	0.000845	CcSEcCtD
Mannitol—Nausea—Irinotecan—pancreatic cancer	0.000288	0.000843	CcSEcCtD
Mannitol—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000287	0.000839	CcSEcCtD
Mannitol—Pain—Docetaxel—pancreatic cancer	0.000287	0.000839	CcSEcCtD
Mannitol—Chills—Epirubicin—pancreatic cancer	0.000286	0.000836	CcSEcCtD
Mannitol—Nausea—Gemcitabine—pancreatic cancer	0.000281	0.000821	CcSEcCtD
Mannitol—Mental disorder—Epirubicin—pancreatic cancer	0.000279	0.000816	CcSEcCtD
Mannitol—Malnutrition—Epirubicin—pancreatic cancer	0.000277	0.000811	CcSEcCtD
Mannitol—Feeling abnormal—Docetaxel—pancreatic cancer	0.000276	0.000808	CcSEcCtD
Mannitol—Nausea—Fluorouracil—pancreatic cancer	0.000276	0.000807	CcSEcCtD
Mannitol—Flatulence—Epirubicin—pancreatic cancer	0.000273	0.000799	CcSEcCtD
Mannitol—Nervousness—Epirubicin—pancreatic cancer	0.000269	0.000788	CcSEcCtD
Mannitol—Back pain—Epirubicin—pancreatic cancer	0.000268	0.000784	CcSEcCtD
Mannitol—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000265	0.000777	CcSEcCtD
Mannitol—Body temperature increased—Docetaxel—pancreatic cancer	0.000265	0.000776	CcSEcCtD
Mannitol—Chills—Doxorubicin—pancreatic cancer	0.000264	0.000773	CcSEcCtD
Mannitol—Vision blurred—Epirubicin—pancreatic cancer	0.000261	0.000764	CcSEcCtD
Mannitol—Mental disorder—Doxorubicin—pancreatic cancer	0.000258	0.000755	CcSEcCtD
Mannitol—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000257	0.000752	CcSEcCtD
Mannitol—Malnutrition—Doxorubicin—pancreatic cancer	0.000256	0.00075	CcSEcCtD
Mannitol—Flatulence—Doxorubicin—pancreatic cancer	0.000253	0.000739	CcSEcCtD
Mannitol—Malaise—Epirubicin—pancreatic cancer	0.00025	0.000731	CcSEcCtD
Mannitol—Nervousness—Doxorubicin—pancreatic cancer	0.000249	0.000729	CcSEcCtD
Mannitol—Vertigo—Epirubicin—pancreatic cancer	0.000249	0.000728	CcSEcCtD
Mannitol—Back pain—Doxorubicin—pancreatic cancer	0.000248	0.000726	CcSEcCtD
Mannitol—Hypersensitivity—Docetaxel—pancreatic cancer	0.000247	0.000723	CcSEcCtD
Mannitol—Cough—Epirubicin—pancreatic cancer	0.000242	0.000708	CcSEcCtD
Mannitol—Vision blurred—Doxorubicin—pancreatic cancer	0.000242	0.000707	CcSEcCtD
Mannitol—Asthenia—Docetaxel—pancreatic cancer	0.000241	0.000704	CcSEcCtD
Mannitol—Convulsion—Epirubicin—pancreatic cancer	0.00024	0.000703	CcSEcCtD
Mannitol—Hypertension—Epirubicin—pancreatic cancer	0.000239	0.0007	CcSEcCtD
Mannitol—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000238	0.000696	CcSEcCtD
Mannitol—Pruritus—Docetaxel—pancreatic cancer	0.000237	0.000694	CcSEcCtD
Mannitol—Arthralgia—Epirubicin—pancreatic cancer	0.000236	0.00069	CcSEcCtD
Mannitol—Chest pain—Epirubicin—pancreatic cancer	0.000236	0.00069	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000234	0.000686	CcSEcCtD
Mannitol—Discomfort—Epirubicin—pancreatic cancer	0.000233	0.000682	CcSEcCtD
Mannitol—Malaise—Doxorubicin—pancreatic cancer	0.000231	0.000677	CcSEcCtD
Mannitol—Vertigo—Doxorubicin—pancreatic cancer	0.00023	0.000674	CcSEcCtD
Mannitol—Diarrhoea—Docetaxel—pancreatic cancer	0.000229	0.000671	CcSEcCtD
Mannitol—Oedema—Epirubicin—pancreatic cancer	0.000226	0.000662	CcSEcCtD
Mannitol—Infection—Epirubicin—pancreatic cancer	0.000225	0.000657	CcSEcCtD
Mannitol—Cough—Doxorubicin—pancreatic cancer	0.000224	0.000655	CcSEcCtD
Mannitol—Convulsion—Doxorubicin—pancreatic cancer	0.000222	0.00065	CcSEcCtD
Mannitol—Nervous system disorder—Epirubicin—pancreatic cancer	0.000222	0.000649	CcSEcCtD
Mannitol—Dizziness—Docetaxel—pancreatic cancer	0.000222	0.000649	CcSEcCtD
Mannitol—Hypertension—Doxorubicin—pancreatic cancer	0.000221	0.000648	CcSEcCtD
Mannitol—Tachycardia—Epirubicin—pancreatic cancer	0.000221	0.000646	CcSEcCtD
Mannitol—Skin disorder—Epirubicin—pancreatic cancer	0.00022	0.000643	CcSEcCtD
Mannitol—Arthralgia—Doxorubicin—pancreatic cancer	0.000218	0.000639	CcSEcCtD
Mannitol—Chest pain—Doxorubicin—pancreatic cancer	0.000218	0.000639	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000217	0.000634	CcSEcCtD
Mannitol—Discomfort—Doxorubicin—pancreatic cancer	0.000216	0.000631	CcSEcCtD
Mannitol—Vomiting—Docetaxel—pancreatic cancer	0.000213	0.000624	CcSEcCtD
Mannitol—Rash—Docetaxel—pancreatic cancer	0.000211	0.000619	CcSEcCtD
Mannitol—Hypotension—Epirubicin—pancreatic cancer	0.000211	0.000618	CcSEcCtD
Mannitol—Dermatitis—Docetaxel—pancreatic cancer	0.000211	0.000618	CcSEcCtD
Mannitol—Headache—Docetaxel—pancreatic cancer	0.00021	0.000615	CcSEcCtD
Mannitol—Oedema—Doxorubicin—pancreatic cancer	0.000209	0.000612	CcSEcCtD
Mannitol—Infection—Doxorubicin—pancreatic cancer	0.000208	0.000608	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000206	0.000603	CcSEcCtD
Mannitol—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000205	0.0006	CcSEcCtD
Mannitol—Tachycardia—Doxorubicin—pancreatic cancer	0.000204	0.000598	CcSEcCtD
Mannitol—Skin disorder—Doxorubicin—pancreatic cancer	0.000203	0.000595	CcSEcCtD
Mannitol—Dyspnoea—Epirubicin—pancreatic cancer	0.000202	0.00059	CcSEcCtD
Mannitol—Nausea—Docetaxel—pancreatic cancer	0.000199	0.000583	CcSEcCtD
Mannitol—Decreased appetite—Epirubicin—pancreatic cancer	0.000197	0.000575	CcSEcCtD
Mannitol—Hypotension—Doxorubicin—pancreatic cancer	0.000196	0.000572	CcSEcCtD
Mannitol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000195	0.000571	CcSEcCtD
Mannitol—Fatigue—Epirubicin—pancreatic cancer	0.000195	0.000571	CcSEcCtD
Mannitol—Pain—Epirubicin—pancreatic cancer	0.000193	0.000566	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000191	0.000558	CcSEcCtD
Mannitol—Dyspnoea—Doxorubicin—pancreatic cancer	0.000187	0.000546	CcSEcCtD
Mannitol—Feeling abnormal—Epirubicin—pancreatic cancer	0.000186	0.000545	CcSEcCtD
Mannitol—Decreased appetite—Doxorubicin—pancreatic cancer	0.000182	0.000532	CcSEcCtD
Mannitol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000181	0.000529	CcSEcCtD
Mannitol—Fatigue—Doxorubicin—pancreatic cancer	0.00018	0.000528	CcSEcCtD
Mannitol—Urticaria—Epirubicin—pancreatic cancer	0.00018	0.000526	CcSEcCtD
Mannitol—Pain—Doxorubicin—pancreatic cancer	0.000179	0.000524	CcSEcCtD
Mannitol—Body temperature increased—Epirubicin—pancreatic cancer	0.000179	0.000523	CcSEcCtD
Mannitol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000172	0.000505	CcSEcCtD
Mannitol—Hypersensitivity—Epirubicin—pancreatic cancer	0.000167	0.000488	CcSEcCtD
Mannitol—Urticaria—Doxorubicin—pancreatic cancer	0.000166	0.000486	CcSEcCtD
Mannitol—Body temperature increased—Doxorubicin—pancreatic cancer	0.000165	0.000484	CcSEcCtD
Mannitol—Asthenia—Epirubicin—pancreatic cancer	0.000162	0.000475	CcSEcCtD
Mannitol—Pruritus—Epirubicin—pancreatic cancer	0.00016	0.000468	CcSEcCtD
Mannitol—Diarrhoea—Epirubicin—pancreatic cancer	0.000155	0.000453	CcSEcCtD
Mannitol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000154	0.000451	CcSEcCtD
Mannitol—Asthenia—Doxorubicin—pancreatic cancer	0.00015	0.000439	CcSEcCtD
Mannitol—Dizziness—Epirubicin—pancreatic cancer	0.00015	0.000438	CcSEcCtD
Mannitol—Pruritus—Doxorubicin—pancreatic cancer	0.000148	0.000433	CcSEcCtD
Mannitol—Vomiting—Epirubicin—pancreatic cancer	0.000144	0.000421	CcSEcCtD
Mannitol—Diarrhoea—Doxorubicin—pancreatic cancer	0.000143	0.000419	CcSEcCtD
Mannitol—Rash—Epirubicin—pancreatic cancer	0.000143	0.000417	CcSEcCtD
Mannitol—Dermatitis—Epirubicin—pancreatic cancer	0.000142	0.000417	CcSEcCtD
Mannitol—Headache—Epirubicin—pancreatic cancer	0.000142	0.000415	CcSEcCtD
Mannitol—Dizziness—Doxorubicin—pancreatic cancer	0.000138	0.000405	CcSEcCtD
Mannitol—Nausea—Epirubicin—pancreatic cancer	0.000134	0.000393	CcSEcCtD
Mannitol—Vomiting—Doxorubicin—pancreatic cancer	0.000133	0.000389	CcSEcCtD
Mannitol—Rash—Doxorubicin—pancreatic cancer	0.000132	0.000386	CcSEcCtD
Mannitol—Dermatitis—Doxorubicin—pancreatic cancer	0.000132	0.000386	CcSEcCtD
Mannitol—Headache—Doxorubicin—pancreatic cancer	0.000131	0.000384	CcSEcCtD
Mannitol—Nausea—Doxorubicin—pancreatic cancer	0.000124	0.000364	CcSEcCtD
